| Free Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Decoded A comprehensive assessment of clinical efficacy, manufacturing scalability, and PBM dynamics shaping the metabolic market. By KAPUALabs / 19 Jun 2026
| Free Meta's AI Capex Gamble: A Definitive Analysis of the Strategic Pivot Examining the risks and rewards of Meta's massive capital expenditure shift from social ads to AI infrastructure. By KAPUALabs / 19 Jun 2026
| Free The Convergence of ESG, AI, and Geopolitics How regulatory fragmentation and technology competition are redefining the rules for Big Tech platforms like Meta. By KAPUALabs / 19 Jun 2026
| Free Meta's Strategic Pivot: Dividends, Cloud & Reality Labs A comprehensive analysis of Meta's financial fortitude, diversification efforts, and the $4B quarterly Reality Labs cash burn. By KAPUALabs / 19 Jun 2026
| Free Meta’s Insider Sales, Structured Notes, and Spinoff: A Full Accounting Why CFO Li’s share sales are tax-driven, not bearish, and what the Goldman notes reveal about institutional demand. By KAPUALabs / 19 Jun 2026
| Free Meta's Strategic Pivot: Subscriptions, Wearables, and AI An in-depth examination of Meta's transition from social media to subscription and wearable ecosystems amid regulatory pressures. By KAPUALabs / 19 Jun 2026
| Free Meta's Smart Glasses: A Bull Case on 50M Units, Bear Case on Privacy Commercial validation meets regulatory overhang—investors face a bifurcated outlook. By KAPUALabs / 19 Jun 2026
| Free The Alchemy of GLP-1: How Eli Lilly Formulated a Therapeutic Revolution From tirzepatide's surgical-level weight loss to oral orforglipron, a story of systematic advantage. By KAPUALabs / 19 Jun 2026
| Free Meta’s AI Capex: Bull Case vs. Bear Case on FCF and ROE Analyzing the bull case of advertising monetization against the bear case of near-zero free cash flow and rising depreciation. By KAPUALabs / 19 Jun 2026
| Free Meta Platforms: Balancing Hardware Innovation with Regulatory and Advertising Pressures A comprehensive analysis of Meta's Ray-Ban smart glasses traction, AI risks, advertising threats, and data privacy concerns. By KAPUALabs / 19 Jun 2026
| Free AI Regulation: Meta's Compliance Maze Navigating fragmented global rules from the EU AI Act to state-level mandates and Vatican ethics By KAPUALabs / 19 Jun 2026
| Free Meta's Bear Case Strengthens: Cybersecurity Risks Threaten Shareholder Value With PII breaches eroding trust and regulatory fines looming, Meta's security flaws become a material headwind. By KAPUALabs / 19 Jun 2026
